Systematic Review of Gossypol/AT-101 in Cancer Clinical Trials

The potential of gossypol and of its R-(−)-enantiomer (R-(−)-gossypol acetic acid, AT-101), has been evaluated for treatment of cancer as an independent agent and in combination with standard chemo-radiation-therapies, respectively. This review assesses the evidence for safety and clinical effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Renner, Olga, Mayer, Mascha, Leischner, Christian, Burkard, Markus, Berger, Alexander, Lauer, Ulrich M., Venturelli, Sascha, Bischoff, Stephan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879263/
https://www.ncbi.nlm.nih.gov/pubmed/35215257
http://dx.doi.org/10.3390/ph15020144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879263/
https://www.ncbi.nlm.nih.gov/pubmed/35215257
http://dx.doi.org/10.3390/ph15020144

Ejemplares similares